Thanks to research funded by the Society, a simple blood test is now used around the world to help researchers pinpoint differences between some cancer types and identify whether treatment is working.
In 1965, Dr. Phil Gold and Dr, Samuel Freedman discovered carcinoembryonic antigen (CEA), which ushered in the modern era of screening blood for the presence of cancer biomarkers. Their discovery has greatly improved cancer screening, early detection and monitoring the effectiveness of treatment.
Since then, researchers have built on their landmark finding to make critically important discoveries in tumour biology.
The Canadian Cancer Society funds more research into more types of cancer than any other national charity in Canada. Learn more about the exciting research we are currently funding.